MERCK Kommanditgesellschaft auf Aktien
MER
Pozycja w akcjach
#323
Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the... Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
Cena akcji
$171.67
Ostatnia synchronizacja: 2026-07-13
Kapitalizacja rynkowa
$74.64B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
-
Kraj
DE
Handel MERCK Kommanditgesellschaft auf Aktien (MER)
Kategoria
Healthcare
Przychody dla MERCK Kommanditgesellschaft auf Aktien (MER)
Przychody w Oct 2026 TTM: 0
Według najnowszych raportów finansowych MERCK Kommanditgesellschaft auf Aktien, obecny przychód firmy (TTM) wynosi 0. W roku 2026 firma osiągnęła przychód w wysokości 0 równa się przychodu z roku 2026, który wynosił 0. Przychód to całkowita kwota dochodu generowana przez firmę ze sprzedaży towarów lub usług. W przeciwieństwie do zysku, nie są odliczane żadne koszty.
Historia przychodów firmy MERCK Kommanditgesellschaft auf Aktien od 2002 do 2026
Przychody na koniec każdego roku
| Rok | Przychody | Zmień |
|---|---|---|
| 2025 | $24.76B | 3.81% |
| 2022 | $23.85B | 6.52% |
| 2021 | $22.39B | 4.84% |
| 2020 | $21.35B | 17.83% |
| 2019 | $18.12B | 6.30% |
| 2018 | $17.05B | -7.30% |
| 2017 | $18.39B | 16.34% |
| 2016 | $15.81B | 13.34% |
| 2015 | $13.95B | 0.23% |
| 2014 | $13.92B | -8.80% |
| 2013 | $15.26B | 3.52% |
| 2012 | $14.74B | 10.79% |
| 2011 | $13.30B | 7.10% |
| 2010 | $12.42B | 11.82% |
| 2009 | $11.11B | 5.46% |
| 2008 | $10.53B | 2.11% |
| 2007 | $10.32B | 25.26% |
| 2006 | $8.23B | 18.73% |
| 2005 | $6.94B | -4.20% |
| 2004 | $7.24B | -20.17% |
| 2003 | $9.07B | 16.80% |
| 2002 | $7.76B | 0.00% |
Przychody podobnych firm lub konkurentów
| Firma | Przychody | Różnica w przychodach | Kraj |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $6.61B | - |
IN
|
|
| - | - |
CN
|
